Comparison of Antimicrobial Treatment Incidence Quantification Based on Detailed Field Data on Animal Level with the Standardized Methodology of the European Medicines Agency in Veal Calves, Switzerland, 2016-2018

基于动物层面详细现场数据和欧洲药品管理局标准化方法对瑞士小牛肉抗菌药物治疗发生率进行量化的比较(2016-2018 年)

阅读:1

Abstract

Precise quantification of antimicrobial treatment incidence (TI) is crucial for benchmarking. Two widespread methods for treatment incidence quantification were compared for agreement. Field data were obtained from 38 veal farms from 2016 to 2018 (1905 calves, 1864 treatments). Calculation of TI(swiss) for calves was based on detailed treatment records using pharmacokinetic values from the Swiss Veterinary Medicines Compendium. The method published by the European Medicines Agency was used to calculate TI in defined daily doses (TI(DDD)). For each calf and treatment, TI(swiss) and TI(DDD) were calculated on level of the antimicrobial class, drug, application route, and farm. The quotient (Q) of TI(swiss) and TI(DDD) was calculated. Divergence in results between the two methods of ≤25% was arbitrarily set as good agreement. The agreement between TI(swiss) and TI(DDD) was mostly good. On class level, good agreement was observed for treatments representing 71.5% of the TI(DDD,) and 74.5% of the total TI(DDD) on drug level. Poor agreement was mainly observed for tylosin and sulfadimidine. The agreement was better for parenteral than for oral treatments (81.6% vs. 72.3%). For practically orientated calculation on farm level, good agreement was observed (77.5% of the TI(DDD)). The TI(DDD) method showed mostly good agreement, especially for parenteral treatments.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。